Logo image of OKLO

OKLO INC (OKLO) Stock Fundamental Analysis

NYSE:OKLO - New York Stock Exchange, Inc. - US02156V1098 - Common Stock - Currency: USD

53.49  -0.89 (-1.64%)

Fundamental Rating

3

Overall OKLO gets a fundamental rating of 3 out of 10. We evaluated OKLO against 46 industry peers in the Electric Utilities industry. OKLO has a great financial health rating, but its profitability evaluates not so good. OKLO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

OKLO had negative earnings in the past year.
OKLO had a negative operating cash flow in the past year.
OKLO Yearly Net Income VS EBIT VS OCF VS FCFOKLO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 -10M -20M -30M

1.2 Ratios

With a Return On Assets value of -192.51%, OKLO is not doing good in the industry: 97.30% of the companies in the same industry are doing better.
The Return On Equity of OKLO (-214.82%) is worse than 97.30% of its industry peers.
Industry RankSector Rank
ROA -192.51%
ROE -214.82%
ROIC N/A
ROA(3y)-118.03%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OKLO Yearly ROA, ROE, ROICOKLO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 100 -100 200 -200 300

1.3 Margins

OKLO does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OKLO Yearly Profit, Operating, Gross MarginsOKLO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023

9

2. Health

2.1 Basic Checks

The number of shares outstanding for OKLO remains at a similar level compared to 1 year ago.
There is no outstanding debt for OKLO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
OKLO Yearly Shares OutstandingOKLO Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M 80M 100M
OKLO Yearly Total Debt VS Total AssetsOKLO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 5M 10M

2.2 Solvency

OKLO has an Altman-Z score of 130.39. This indicates that OKLO is financially healthy and has little risk of bankruptcy at the moment.
OKLO has a better Altman-Z score (130.39) than 100.00% of its industry peers.
There is no outstanding debt for OKLO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 130.39
ROIC/WACCN/A
WACCN/A
OKLO Yearly LT Debt VS Equity VS FCFOKLO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 -10M -20M -30M

2.3 Liquidity

OKLO has a Current Ratio of 48.45. This indicates that OKLO is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 48.45, OKLO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
A Quick Ratio of 48.45 indicates that OKLO has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 48.45, OKLO belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 48.45
Quick Ratio 48.45
OKLO Yearly Current Assets VS Current LiabilitesOKLO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 5M 10M

0

3. Growth

3.1 Past

OKLO shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -6870.59%.
EPS 1Y (TTM)-6870.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

OKLO is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -14.46% yearly.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-1686.67%
EPS Next 2Y-17.22%
EPS Next 3Y-14.46%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OKLO Yearly Revenue VS EstimatesOKLO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026
OKLO Yearly EPS VS EstimatesOKLO Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 -1 -2 -3 -4

0

4. Valuation

4.1 Price/Earnings Ratio

OKLO reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year OKLO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OKLO Price Earnings VS Forward Price EarningsOKLO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OKLO Per share dataOKLO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -5 -10

4.3 Compensation for Growth

A cheap valuation may be justified as OKLO's earnings are expected to decrease with -14.46% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-17.22%
EPS Next 3Y-14.46%

0

5. Dividend

5.1 Amount

No dividends for OKLO!.
Industry RankSector Rank
Dividend Yield N/A

OKLO INC

NYSE:OKLO (2/13/2025, 3:08:09 PM)

53.49

-0.89 (-1.64%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryElectric Utilities
Earnings (Last)11-14 2024-11-14/amc
Earnings (Next)02-25 2025-02-25
Inst Owners40.05%
Inst Owner ChangeN/A
Ins Owners22.44%
Ins Owner Change13.6%
Market Cap6.53B
Analysts80
Price Target33.15 (-38.03%)
Short Float %16.86%
Short Ratio0.67
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-175.11%
Min EPS beat(2)-344.24%
Max EPS beat(2)-5.99%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)44.44%
PT rev (3m)200.04%
EPS NQ rev (1m)1.81%
EPS NQ rev (3m)25%
EPS NY rev (1m)-14.46%
EPS NY rev (3m)-46.6%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 24.81
P/tB 24.81
EV/EBITDA N/A
EPS(TTM)-11.85
EYN/A
EPS(NY)-0.36
Fwd EYN/A
FCF(TTM)-0.25
FCFYN/A
OCF(TTM)-0.25
OCFYN/A
SpS0
BVpS2.16
TBVpS2.16
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -192.51%
ROE -214.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-118.03%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 139.46%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 48.45
Quick Ratio 48.45
Altman-Z 130.39
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)972.54%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-6870.59%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-14.29%
EPS Next Y-1686.67%
EPS Next 2Y-17.22%
EPS Next 3Y-14.46%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-213.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-146.19%
EBIT Next 3Y-43.42%
EBIT Next 5YN/A
FCF growth 1Y-58.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-60.1%
OCF growth 3YN/A
OCF growth 5YN/A